Beware -- Not Only do Statins Increase Diabetes Risk but they Will be Used for Inflammation

The U.S. Federal Drug Administration's decision to approve Crestor, a cholesterol-lowering drug, for a much wider audience as a preventative treatment has raised concerns among some in the medical community.

The FDA's approval hinges essentially on a change in the criteria used to assess an adult's risk of developing heart disease or suffering strokes.

Previously, doctors sought evidence of high levels of "bad" cholesterol in the bloodstream before prescribing statin drugs.  Under the new evaluation process approved for Crestor by the FDA, doctors who detect certain levels of inflammation in the blood stream, in addition to one or more common risk factors for heart disease, such as smoking or elevated blood pressure, can prescribe the drug.

Concerns include the new evidence from a study published in The Lancet which shows people on statins have a 9 percent greater risk of developing Type 2 diabetes.
Click Here and be the first to comment on this article
Post your comment